Citadel Advisors’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,416
| Closed | -$192K | – | 6593 |
|
|
2025
Q1 | $192K | Buy |
+16,416
| New | +$192K | ﹤0.01% | 4894 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6499 |
|
|
2023
Q4 | – | Sell |
-5,490
| Closed | -$86.7K | – | 6405 |
|
|
2023
Q3 | $86.7K | Buy |
5,490
+3,095
| +129% | +$48.9K | ﹤0.01% | 4891 |
|
|
2023
Q2 | $39.8K | Buy |
+2,395
| New | +$39.8K | ﹤0.01% | 5065 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6331 |
|
|
2022
Q3 | – | Sell |
-3,975
| Closed | -$82K | – | 6419 |
|
|
2022
Q2 | $82K | Buy |
3,975
+2,958
| +291% | +$61K | ﹤0.01% | 5362 |
|
|
2022
Q1 | $39K | Buy |
1,017
+153
| +18% | +$5.87K | ﹤0.01% | 5982 |
|
|
2021
Q4 | $83K | Sell |
864
-254
| -23% | -$24.4K | ﹤0.01% | 5996 |
|
|
2021
Q3 | $161K | Buy |
1,118
+590
| +112% | +$85K | ﹤0.01% | 5559 |
|
|
2021
Q2 | $97K | Sell |
528
-74
| -12% | -$13.6K | ﹤0.01% | 5980 |
|
|
2021
Q1 | $148K | Sell |
602
-1,791
| -75% | -$440K | ﹤0.01% | 5611 |
|
|
2020
Q4 | $675K | Sell |
2,393
-15,845
| -87% | -$4.47M | ﹤0.01% | 3600 |
|
|
2020
Q3 | $4.38M | Buy |
18,238
+15,601
| +592% | +$3.74M | ﹤0.01% | 1602 |
|
|
2020
Q2 | $875K | Sell |
2,637
-1,919
| -42% | -$637K | ﹤0.01% | 2969 |
|
|
2020
Q1 | $1.04M | Buy |
+4,556
| New | +$1.04M | ﹤0.01% | 2834 |
|
|
2019
Q2 | – | Sell |
-548
| Closed | -$30K | – | 4941 |
|
|
2019
Q1 | $30K | Sell |
548
-1,324
| -71% | -$72.5K | ﹤0.01% | 4353 |
|
|
2018
Q4 | $81K | Sell |
1,872
-9,894
| -84% | -$428K | ﹤0.01% | 4049 |
|
|
2018
Q3 | $689K | Buy |
11,766
+5,533
| +89% | +$324K | ﹤0.01% | 2969 |
|
|
2018
Q2 | $330K | Buy |
+6,233
| New | +$330K | ﹤0.01% | 3387 |
|
|
2018
Q1 | – | Sell |
-533
| Closed | -$125K | – | 4256 |
|
|
2017
Q4 | $125K | Sell |
533
-151
| -22% | -$35.4K | ﹤0.01% | 3485 |
|
|
2017
Q3 | $194K | Buy |
+684
| New | +$194K | ﹤0.01% | 3214 |
|